A Diagnostics & Imaging Week

PerkinElmer (Wellesley, Massachusetts), a leader in health sciences and photonics, said it has sold the assets of its semiconductor components business to Tara Capital for cash and assumed liabilities totaling about $26.5 million and an earnout that could increase the total consideration to in excess of $30 million.

This sale represents the last of three recent divestitures that comprised PerkinElmer's Fluid Sciences unit. As previously disclosed, the company had sold its aerospace and fluid-testing businesses at the end of 2005, and has realized a total of about $400 million for the three businesses.

Health sciences end markets include genetic screening, environmental, service, biopharma and medical imaging, while photonics markets include sensors and specialty lighting.

No Comments